InvestorsHub Logo

McMagyar

11/22/23 8:45 AM

#439755 RE: sokol #439751

Dang it everybody
It will provide benefit to all humanity!

Put this stuff in the water!!!

nidan7500

11/22/23 8:52 AM

#439760 RE: sokol #439751

Does Anavex have convincing evidence or data to show that Blarcamesine treats insomnia, anxiety and agitation? Will this provide some collateral benefit for EMA or other regulatory approval?



See recently approved U.S. PATENT ...

kevindenver

11/22/23 9:44 AM

#439772 RE: sokol #439751

Yes, some of the best evidence from sleep quality and insomnia is from the PDD studies and trials where RSBDQ (REM Sleep Behavior Disorder Screening Questionnaire) was a secondary outcome measure.

Does Anavex have convincing evidence or data to show that Blarcamesine treats insomnia, anxiety and agitation? Will this provide some collateral benefit for EMA or other regulatory approval?

Bullish
Bullish

Investor2014

11/22/23 10:06 AM

#439781 RE: sokol #439751

All we really know so far is that Anavex stated sleep did not get worse by taking A2-73, no hard data published so far AFAIK. As in the open label P2 AD trial is not in my book hard data.